Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiviral Activity and Tolerability of PEG-Intron in HIV-Infected Subjects Failing HAART

NCT00005012 is registered in ClinicalTrials.gov with Schering-Plough as lead sponsor.

NCT NCT00005012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiviral Activity and Tolerability of PEG-Intron in HIV-Infected Subjects Failing HAART
Lead sponsor
Schering-Plough
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2000
Completion date
September 30, 2000
Enrollment
250
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections